UnitedHealth Group (NYSE: UNH) reported second quarter earnings of $3.74 per share and updated its full-year 2025 financial outlook after previously suspending guidance in May.

The company expects 2025 revenues between $445.5 billion and $448.0 billion, with net earnings of at least $14.65 per share and adjusted earnings of at least $16.00 per share. UnitedHealth Group anticipates returning to earnings growth in 2026.

Second quarter revenues increased to $111.6 billion from $98.9 billion in the prior year period. However, earnings from operations declined to $5.2 billion from $7.9 billion year-over-year, while the net margin compressed to 3.1% from 4.3%.

The company's medical care ratio reached 89.4% in the second quarter, an increase of 430 basis points compared to the same period last year. Medical cost trends significantly exceeded pricing trends, including both unit costs and service intensity. The full-year 2025 medical cost ratio is expected to be 89.25% plus or minus 25 basis points.

UnitedHealthcare's second quarter operating margin fell to 2.4% from 5.4% in the prior year, primarily due to higher medical cost trends and Medicare funding reductions. The division served 50 million people in the second quarter, an increase of 770,000 year-to-date.

Optum's second quarter operating margin was 4.6% compared to 6.2% in the prior year period. Optum Health revenues declined 7% year-over-year to $25.2 billion, while Optum Rx revenues grew 19% to $38.5 billion.

The company returned $4.5 billion to shareholders through dividends and share repurchases in the second quarter and increased its quarterly dividend rate by 5% to $2.21. Cash flows from operations were $7.2 billion, representing 2.0 times net income.